logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10729666 B1

PDFFull Text
Date of Patent:
Aug. 04, 2020

Filed:

Aug. 28, 2015

Use of gabaa receptor reinforcing agent in preparation of sedative and anesthetic medicament

Applicant:

Sichuan Haisco Pharmaceutical Co., Ltd., Chengdu, CN;

Inventors:

Yi Mo, Chengdu, CN;

Fangqiong Li, Chengdu, CN;

Jianyu Liu, Chengdu, CN;

Yan Yu, Chengdu, CN;

Honghu Li, Chengdu, CN;

Hong Mu, Chengdu, CN;

Yuquan Zhang, Chengdu, CN;

Qingyang Yu, Chengdu, CN;

Fujun Cheng, Chengdu, CN;

Pangke Yan, Chengdu, CN;

Ziwei Zhao, Chengdu, CN;

Linlin Qin, Chengdu, CN;

Assignee:

HAISCO CHENGDU PHARMACEUTICAL TECHNOLOGY CO., LTD., Chengdu, Sichuan, CN;

Attorney:

Ohlandt, Greeley, Ruggiero & Perle, LLP

Primary Examiner:

Lakshmi S Channavajjala

Int. Cl.
CPC ...
A61K 31/05 (2006.01); A61P 25/20 (2006.01); A61K 9/08 (2006.01); A61K 9/107 (2006.01); A61K 9/19 (2006.01); A61P 1/08 (2006.01); A61P 25/08 (2006.01); A61K 45/06 (2006.01); A61P 25/24 (2006.01); A61P 25/22 (2006.01); A61P 25/18 (2006.01); A61P 25/06 (2006.01); C07F 9/09 (2006.01); A61K 31/661 (2006.01); A61J 1/18 (2006.01); A61K 9/00 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/14 (2017.01); A61K 47/18 (2017.01); A61K 47/24 (2006.01); A61K 47/26 (2006.01); A61K 47/44 (2017.01);
U.S. Cl.
CPC ...
A61K 31/05 (2013.01); A61J 1/18 (2013.01); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 9/107 (2013.01); A61K 9/19 (2013.01); A61K 31/661 (2013.01); A61K 45/06 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/18 (2013.01); A61K 47/183 (2013.01); A61K 47/24 (2013.01); A61K 47/26 (2013.01); A61K 47/44 (2013.01); A61P 1/08 (2018.01); A61P 25/06 (2018.01); A61P 25/08 (2018.01); A61P 25/18 (2018.01); A61P 25/20 (2018.01); A61P 25/22 (2018.01); A61P 25/24 (2018.01); C07F 9/091 (2013.01);
Abstract

The present disclosure provides a pharmaceutical preparation of a compound of formula (I) or a stereoisomer, pharmaceutically acceptable salt, or prodrug thereof. The present disclosure further provides a method for general anesthesia or sedation for mammals. Also provided are kits and manufactured products of the medicament and the pharmaceutical composition and a method for using the medicament and the pharmaceutical composition.

Find Patent Forward Citations

Loading…